Helio Genomics has announced that its ‘sister company’ Laboratory for Advanced Medicine & Health Group (LAMH) has achieved a significant milestone with the National Medical Product Administration (NMPA)’s first-ever approval for a liver cancer-related liquid biopsy test in China. This approval marks a breakthrough in non-invasive diagnostic testing for liver…